Changes

Jump to navigation Jump to search

Apligraf

30 bytes removed, 16:56, 27 December 2021
m
wikify skin
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->'''Apligraf''' is a synthetic [[skin]] created from harvested foreskins.<ref>{{Construction SiteREFweb |quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins |url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ |title=Apligraf: How Is It Made? |last= |first= |publisher=Organogenesis |date= |accessdate=2011-03-06}}</ref> It is [[FDA]] approved,<ref>{{REFweb |quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). |url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html |title=Apligraf |last= |first= |publisher=Organogenesis |date= |accessdate=2011-03-06}}</ref> and it is made and sold by [[Organogenesis]], a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
[[Image:Alloderm-logo.jpg|right|thumb|]]Apligraf is a synthetic skin created from harvested foreskins.<ref>{{cite web | url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | title = Apligraf: How Is It Made? | accessdate Apligraph Oral = 2011-03-06 | publisher = Organogenesis | quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins}}</ref> It is [[FDA]] approved,<ref>{{cite web | url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | title = Apligraf | accessdate = 2011-03-06 | publisher = Organogenesis | quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews |last= |first= |url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript |date=2011-11-17 |publisher=Apligraph OralFDA |quote= |accessdate=2011-12-20}}</ref><!-- 404: Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf -->{{REF}}
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived [[Category:Foreskin product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting]][[Category: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>Financial gain]]
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf ==<small>References</small>==<div class='references-small'><references/></div> [[Category:Foreskin ProductsFrom CircLeaks]][[Category:Financial Gain]][[Category:CircLeaksFrom IntactWiki]]
[[Categoryde:Construction Site]][[Category:From IntactWiki{{FULLPAGENAME}}]]
administrator, administrators, Bureaucrats, Interface administrators, Administrators
22,208
edits

Navigation menu